THTX: Theratechnologies Inc Financial Statements

Balance sheet, income statement, and cash flow statements for Theratechnologies Inc (THTX).

OverviewDividends

$55.64M Market Cap.

As of 02/26/2025 5:00 PM ET (MRY) • Disclaimer

THTX Market Cap. (MRY)


THTX Shares Outstanding (MRY)


THTX Assets (MRY)


Total Assets

$53.34M

Total Liabilities

$78.61M

Total Investments

$3.94M

THTX Income (MRY)


Revenue

$85.87M

Net Income

-$8.31M

Operating Expense

$57.24M

THTX Cash Flow (MRY)


CF Operations

$2.38M

CF Investing

$942.00K

CF Financing

-$21.49M

THTX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$53,340,000 (-31.41%)

$77,769,000 (-16.61%)

$93,260,000 (-21.77%)

$119,212,000 (19.04%)

Assets Current

$43,980,000 (-30.52%)

$63,297,000 (-13.73%)

$73,370,000 (-20.17%)

$91,908,000 (41.82%)

Assets Non-Current

$9,360,000 (-35.32%)

$14,472,000 (-27.24%)

$19,890,000 (-27.15%)

$27,304,000 (-22.73%)

Goodwill & Intangible Assets

$7,568,000 (-39.44%)

$12,496,000 (-16.74%)

$15,009,000 (-29.83%)

$21,388,000 (-12.81%)

Shareholders Equity

-$25,272,000 (-21.09%)

-$20,870,000 (7.54%)

-$22,571,000 (-227.09%)

$17,760,000 (450.87%)

Property Plant & Equipment Net

$1,258,000 (-36.34%)

$1,976,000 (-36.03%)

$3,089,000 (8.23%)

$2,854,000 (-18.06%)

Cash & Equivalents

$15,899,000 (-53.37%)

$34,097,000 (42.93%)

$23,856,000 (16.95%)

$20,399,000 (60.16%)

Accumulated Other Comprehensive Income

$898,000 (31.29%)

$684,000 (77.66%)

$385,000 (975.00%)

-$44,000 (90.85%)

Deferred Revenue

$38,000 (0.00%)

$38,000 (0.00%)

$38,000 (-29.63%)

$54,000 (8.00%)

Total Investments

$3,937,000 (-37.41%)

$6,290,000 (-31.73%)

$9,214,000 (-53.83%)

$19,955,000 (148.47%)

Investments Current

$3,723,000 (-40.81%)

$6,290,000 (-31.73%)

$9,214,000 (-53.83%)

$19,955,000 (148.47%)

Investments Non-Current

$214,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$5,281,000 (-12.94%)

$6,066,000 (-69.19%)

$19,688,000 (-32.44%)

$29,141,000 (15.89%)

Trade & Non-Trade Receivables

$15,218,000 (16.85%)

$13,023,000 (8.12%)

$12,045,000 (14.86%)

$10,487,000 (-15.63%)

Trade & Non-Trade Payables

$24,149,000 (-15.18%)

$28,471,000 (-30.67%)

$41,065,000 (1.71%)

$40,376,000 (15.97%)

Accumulated Retained Earnings (Deficit)

-$416,887,000 (-2.01%)

-$408,659,000 (-6.80%)

-$382,649,000 (-14.14%)

-$335,248,000 (-11.70%)

Tax Assets

$435,000 (-21.90%)

$557,000 (86.29%)

$299,000 (-32.20%)

$441,000 (-41.59%)

Tax Liabilities

$19,000 (0%)

$0 (0%)

$394,000 (556.67%)

$60,000 (275.00%)

Total Debt

$45,606,000 (-22.66%)

$58,968,000 (-11.61%)

$66,711,000 (17.56%)

$56,745,000 (2.46%)

Debt Current

$3,876,000 (-49.71%)

$7,707,000 (-88.19%)

$65,265,000 (13996.11%)

$463,000 (8.94%)

Debt Non-Current

$41,730,000 (-18.59%)

$51,261,000 (3445.02%)

$1,446,000 (-97.43%)

$56,282,000 (2.41%)

Total Liabilities

$78,612,000 (-20.30%)

$98,639,000 (-14.84%)

$115,831,000 (14.17%)

$101,452,000 (4.68%)

Liabilities Current

$36,861,000 (-22.06%)

$47,294,000 (-58.62%)

$114,279,000 (153.53%)

$45,076,000 (7.53%)

Liabilities Non-Current

$41,751,000 (-18.69%)

$51,345,000 (3208.31%)

$1,552,000 (-97.25%)

$56,376,000 (2.50%)

THTX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$85,866,000 (5.02%)

$81,764,000 (2.13%)

$80,057,000 (14.66%)

$69,823,000 (5.71%)

Cost of Revenue

$20,448,000 (4.14%)

$19,635,000 (-17.63%)

$23,838,000 (29.71%)

$18,378,000 (-16.54%)

Selling General & Administrative Expense

$40,271,000 (-4.99%)

$42,386,000 (-25.31%)

$56,747,000 (30.38%)

$43,525,000 (11.35%)

Research & Development Expense

$16,973,000 (-44.11%)

$30,370,000 (-17.78%)

$36,939,000 (30.65%)

$28,274,000 (56.91%)

Operating Expenses

$57,244,000 (-21.32%)

$72,756,000 (-24.31%)

$96,127,000 (25.36%)

$76,681,000 (23.70%)

Interest Expense

$16,461,000 (9.33%)

$15,056,000 (99.18%)

$7,559,000 (14.17%)

$6,621,000 (22.36%)

Income Tax Expense

$2,005,000 (376.25%)

$421,000 (-4.97%)

$443,000 (603.17%)

$63,000 (293.75%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$8,306,000 (65.33%)

-$23,957,000 (49.28%)

-$47,237,000 (-48.90%)

-$31,725,000 (-39.96%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$8,306,000 (65.33%)

-$23,957,000 (49.28%)

-$47,237,000 (-48.90%)

-$31,725,000 (-39.96%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$8,306,000 (65.33%)

-$23,957,000 (49.28%)

-$47,237,000 (-48.90%)

-$31,725,000 (-39.96%)

Weighted Average Shares

$45,980,019 (89.99%)

$24,201,835 (1.75%)

$23,785,410 (0.03%)

$23,777,535 (23.59%)

Weighted Average Shares Diluted

-

-

-

-

Earning Before Interest & Taxes (EBIT)

$10,160,000 (219.81%)

-$8,480,000 (78.39%)

-$39,235,000 (-56.68%)

-$25,041,000 (-45.25%)

Gross Profit

$65,418,000 (5.29%)

$62,129,000 (10.51%)

$56,219,000 (9.28%)

$51,445,000 (16.84%)

Operating Income

$8,174,000 (176.92%)

-$10,627,000 (73.37%)

-$39,908,000 (-58.14%)

-$25,236,000 (-40.54%)

THTX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$942,000 (-14.98%)

$1,108,000 (-87.24%)

$8,682,000 (168.17%)

-$12,736,000 (-366.67%)

Net Cash Flow from Financing

-$21,487,000 (-245.43%)

$14,775,000 (53.01%)

$9,656,000 (-74.50%)

$37,863,000 (623.77%)

Net Cash Flow from Operations

$2,379,000 (141.90%)

-$5,678,000 (61.35%)

-$14,692,000 (16.05%)

-$17,501,000 (-29.12%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$18,166,000 (-278.01%)

$10,205,000 (179.90%)

$3,646,000 (-52.19%)

$7,626,000 (147.64%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$2,383,000 (-18.56%)

$2,926,000 (-69.73%)

$9,667,000 (176.91%)

-$12,570,000 (-385.23%)

Capital Expenditure

$0 (0%)

-$318,000 (67.72%)

-$985,000 (-675.59%)

-$127,000 (-296.88%)

Issuance (Repayment) of Debt Securities

-$20,817,000 (-141.95%)

-$8,604,000 (-203.78%)

$8,291,000 (247.13%)

-$5,635,000 (-38.52%)

Issuance (Purchase) of Equity Shares

-$505,000 (-102.14%)

$23,575,000 (715.18%)

$2,892,000 (-93.42%)

$43,945,000 (30206.90%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$32,000 (-188.89%)

$36,000 (119.05%)

-$189,000 (-625.00%)

$36,000 (-56.63%)

Share Based Compensation

$3,549,000 (60.23%)

$2,215,000 (-39.33%)

$3,651,000 (70.53%)

$2,141,000 (68.58%)

Depreciation Amortization & Accretion

$2,761,000 (-16.71%)

$3,315,000 (-73.42%)

$12,471,000 (42.56%)

$8,748,000 (2.68%)

THTX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

76.20% (0.26%)

76.00% (8.26%)

70.20% (-4.75%)

73.70% (10.49%)

Profit Margin

-9.70% (66.89%)

-29.30% (50.34%)

-59.00% (-29.96%)

-45.40% (-32.36%)

EBITDA Margin

15.00% (338.10%)

-6.30% (81.14%)

-33.40% (-43.35%)

-23.30% (-76.52%)

Return on Average Equity (ROAE)

35.80% (-49.00%)

70.20% (-84.35%)

448.60% (524.81%)

-105.60% (44.27%)

Return on Average Assets (ROAA)

-12.50% (63.13%)

-33.90% (29.52%)

-48.10% (-95.53%)

-24.60% (-14.95%)

Return on Sales (ROS)

11.80% (213.46%)

-10.40% (78.78%)

-49.00% (-36.49%)

-35.90% (-37.55%)

Return on Invested Capital (ROIC)

29.40% (189.91%)

-32.70% (53.42%)

-70.20% (-137.16%)

-29.60% (-46.53%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-9.89 (-41125.00%)

-0.02 (99.58%)

-5.67 (54.39%)

-12.42 (-20.50%)

Price to Sales Ratio (P/S)

0.9 (39.69%)

0.65 (-80.84%)

3.37 (-41.48%)

5.75 (65.20%)

Price to Book Ratio (P/B)

-3.06 (-21.04%)

-2.53 (78.83%)

-11.94 (-152.79%)

22.62 (-68.30%)

Debt to Equity Ratio (D/E)

-3.11 (34.17%)

-4.73 (7.91%)

-5.13 (-189.85%)

5.71 (-81.00%)

Earnings Per Share (EPS)

-0.17 (99.81%)

-91 (-4450.00%)

-2 (-47.06%)

-1.36 (-17.24%)

Sales Per Share (SPS)

1.34 (-45.14%)

2.45 (-3.28%)

2.53 (10.33%)

2.29 (-13.14%)

Free Cash Flow Per Share (FCFPS)

0.05 (120.97%)

-0.25 (62.37%)

-0.66 (11.07%)

-0.74 (-4.96%)

Book Value Per Share (BVPS)

-0.55 (36.19%)

-0.86 (9.17%)

-0.95 (-227.04%)

0.75 (344.64%)

Tangible Assets Book Value Per Share (TABVPS)

0.99 (-63.11%)

2.7 (-18.02%)

3.29 (-20.03%)

4.11 (4.68%)

Enterprise Value Over EBIT (EV/EBIT)

10 (190.91%)

-11 (-37.50%)

-8 (52.94%)

-17 (-6.25%)

Enterprise Value Over EBITDA (EV/EBITDA)

7.83 (141.97%)

-18.66 (-60.55%)

-11.62 (55.55%)

-26.14 (16.24%)

Asset Turnover

1.29 (11.74%)

1.16 (42.09%)

0.81 (50.09%)

0.54 (-12.84%)

Current Ratio

1.19 (-10.84%)

1.34 (108.41%)

0.64 (-68.51%)

2.04 (31.89%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$2,379,000 (139.68%)

-$5,996,000 (61.75%)

-$15,677,000 (11.07%)

-$17,628,000 (-29.75%)

Enterprise Value (EV)

$72,779,527 (4.23%)

$69,825,031 (-70.14%)

$233,823,430 (-29.73%)

$332,761,884 (58.94%)

Earnings Before Tax (EBT)

-$6,301,000 (73.23%)

-$23,536,000 (49.70%)

-$46,794,000 (-47.79%)

-$31,662,000 (-39.78%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$12,921,000 (350.16%)

-$5,165,000 (80.70%)

-$26,764,000 (-64.27%)

-$16,293,000 (-86.85%)

Invested Capital

$38,618,000 (-9.88%)

$42,850,000 (527.65%)

$6,827,000 (-92.34%)

$89,094,000 (16.71%)

Working Capital

$7,119,000 (-55.51%)

$16,003,000 (139.12%)

-$40,909,000 (-187.35%)

$46,832,000 (104.61%)

Tangible Asset Value

$45,772,000 (-29.88%)

$65,273,000 (-16.59%)

$78,251,000 (-20.01%)

$97,824,000 (29.37%)

Market Capitalization

$55,635,823 (45.50%)

$38,238,899 (-81.13%)

$202,651,691 (-35.43%)

$313,863,459 (77.33%)

Average Equity

-$23,189,750 (32.00%)

-$34,104,000 (-223.91%)

-$10,528,750 (-135.04%)

$30,049,000 (151.28%)

Average Assets

$66,339,000 (-6.04%)

$70,607,000 (-28.16%)

$98,286,000 (-23.63%)

$128,704,250 (21.40%)

Invested Capital Average

$34,577,500 (33.14%)

$25,970,000 (-53.54%)

$55,902,500 (-33.93%)

$84,615,000 (-0.88%)

Shares

45,980,019 (89.99%)

24,201,835 (1.75%)

23,785,410 (0.03%)

23,777,535 (23.59%)